RxDoctor Payments Data

Tatiana Hernandez, MD

Family Medicine · Trinity, FLNPI 1366535320

Payments from drug & device makers

$1,807,780in general payments, 2019–2025

Across 498 payments — averaging $3630.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$631K
  • Eli Lilly$531K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$305K
  • GSK$132K
  • Bristol Myers Squibb$82K
  • Ferring International Pharmascience Center US$48K
  • plus $80K from 37 others
$26,153in research payments, 2019–2025

Across 4 payments — averaging $6538.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$26K

What the payments were for

  • Travel & lodging$2,87235%
  • Food & beverage$5,28564%
  • Education$1262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,807,780 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$36,513
Medicare patients
100
Services billed
306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban88$93,438
JanuviaSitagliptin Phosphate41$47,295
MounjaroTirzepatide29$36,386
JardianceEmpagliflozin32$33,499
FarxigaDapagliflozin Propanediol29$29,703
XareltoRivaroxaban21$29,557
OzempicSemaglutide23$27,721
ProliaDenosumab12$20,861
LinzessLinaclotide20$20,027
EntrestoSacubitril/Valsartan11$12,034
LantusInsulin Glargine,hum.Rec.Anlog37$9,868
Albuterol Sulfate HfaAlbuterol Sulfate305$8,169
Humalog Kwikpen U-200Insulin Lispro14$7,862
SymbicortBudesonide/Formoterol Fumarate29$7,567
Fluticasone-SalmeterolFluticasone Propion/Salmeterol49$6,849

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$179$93,43888 claims
MerckJanuvia$47$47,29541 claims
AstraZenecaFarxiga, Symbicort$739$37,27058 claims
Lilly USA, LLCMounjaro$514$36,38629 claims
Boehringer IngelheimJardiance$289$33,49932 claims
Johnson & JohnsonXarelto$195$29,55721 claims
Novo NordiskOzempic$312$27,72123 claims
AmgenProlia$248$20,86112 claims
AbbVieLinzess$322$20,02720 claims
NovartisEntresto$143$12,03411 claims
Sanofi-aventis U.S. LLCLantus$28$9,86837 claims
Dr.reddy's Laboratories,inc.Pregabalin$12,155$2,58745 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Trinity

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →